Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
5
6
7
8
9
10
11
12
13
14
15
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
288
576
864
1152
1440
1728
2016
2304
2592
2880
CT-RD06
/ Nanjing Bioheng Biotech
CTD401
/ Nanjing Bioheng Biotech
DI Leu16 IL-2
/ Provenance, Alopexx
EGFR bi-armed autologous activated T cells
/ Barbara Ann Karmanos Cancer Institute
ERY974
/ Roche
ES014
/ Elpiscience
ESG206
/ Escugen Biotechnology
ET-190
/ Eureka Therap
FT596
/ Fate Therap
GC019F
/ AstraZeneca
GZ402668
/ Sanofi
HB0025
/ Zhejiang Huahai Pharma
HY004
/ Juventas Cell Therapy
HepTcell
(FP-02.2) / Altimmune
Hu-Mik-Beta-1
/ National Institute of Neurological Disorders and Stroke
IBI-325
/ Innovent Biologics
IBI321
/ Innovent Biologics, Eli Lilly
ICG122
/ iCell Gene Therap
INCB99318
/ Incyte
IO-108
/ Immune-Onc Therap
IPH5201
/ AstraZeneca, Innate
JCAR014
/ BMS
JHL1101
(rituximab biosimilar) / Eden Biologics, Sanofi
JNJ-8543
/ J&J
JNJ-9530
/ J&J
KQ-2003
/ Novatim Immune Therap
LMY-920
/ Luminary Therap
LUCAR-20S CAR-T cells
/ Legend Biotech
Lu AG22515
/ Lundbeck
MB-106
/ Fortress
MB-CART20.1
/ Miltenyi Biotec
MK-1045
/ Merck (MSD)
MK-8808
(rituximab biosimilar) / Merck (MSD)
NG-641
/ Akamis Bio
NIP-022
/ Nissan Chemical Corp
Nurdati
(prolgolimab/nurulimab) / Biocad
OBT076
/ Menarini, Oxford BioTherap
OPT101
/ Op-T
PE0116
/ HyaMab
PM1009
/ BioNTech
PM8001
/ BioNTech
PRS-344
/ Pieris Pharmaceuticals
PRV-3279
/ Sanofi
QLS31905
/ Qilu Pharma
SAIT101
(rituximab biosimilar) / Archigen Biotech
SG301 IV
/ Sumgen Biotech
SHR-2002
/ Jiangsu Hengrui Pharma
SHR-A1912
/ Jiangsu Hengrui Pharma
Senl 1904B
/ SenlangBio
T-Guard
(SPV-T3a-RTA/WT1-RTA) / Xenikos
«
1
2
...
5
6
7
8
9
10
11
12
13
14
15
...
27
28
»
